| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Campbell DB, Turner P |
Plasma concentrations of fenfluramine and its metabolite, norfenfluram... |
Br J Pharmacol |
1971 |
| Everitt BJ, Fuxe K, Hokfe... |
Serotonin, Catecholamines and Sexual Receptivity of Female Rats, Pharm... |
J Pharmacol |
1975 |
| Griffith JD, Nutt JG, Jas... |
A comparison of fenfluramine and amphetamine in man |
Clin Pharmacol Ther |
1975 |
| Twente RT,Theeuwen ABE,Ve... |
Enige ervaringen met een gaschromatografische methode voor kwalitatief... |
Pharm.Weekbl. |
1975 |
| Herman ZS |
5-Hydroxytptamine Metabolism in the Brain Under the Influence of Psych... |
Pol.J.Pharmacol.Phar... |
1975 |
| Holz WC, Gill CA |
Drug Injections as Negative Reinforcers. |
Pharmacol.Rev. |
1975 |
| Maj J, Gancarczyk L, Gora... |
Doxepin as a Blocker of Central Serotonin Receptors |
Pharmacopsychiat. |
1977 |
| Palider W, Rawlow A |
Effect of Serotonin Uptake Blocking Agents on the Flexor Reflex of Hin... |
Pol.J.Pharmacol.Phar... |
1977 |
| Appel JB, White FJ, Kuhn ... |
The Use of Drugs as Discriminative Stimuli in Behavioral Pharmacodynam... |
Psychopharmacology |
1978 |
| Gever MA, Dawsey WJ, Mand... |
Fading: A New Cytofluorimetric Measure Quantifying Serotonin in the P... |
J.Pharmacol.Exp.Ther... |
1978 |
| Luellmann H, Luellmann Ra... |
Lipidosis Induced ByAmiphiphilic Drugs |
Biochem.Pharmacol. |
1978 |
| Maj J, Baran L, Michaluk ... |
The Central Antiserotonin Activity of Neuroleptics |
Pol.J.Pharmacol.Phar... |
1978 |
| Maj J, Sowinska H, Baran ... |
The Central Antiserotonergic Action of Mianserin |
Psychopharmacology |
1978 |
| Trulson NE, Jacobs BL |
Behavioral Evidence for Denervation Supersensitivity After Destruction... |
Ann.N.Y.Acad.Sci. |
1978 |
| Whitaker PM, Seeman P |
Selective labeling of serotonin receptors by d-[3H]lysergic acid dieth... |
Proc.Natl.Acad.Sci. |
1978 |
| Winter JC |
LSD-Induced Stimulus Control: A Comparison of SCH12,679, Fenfluramine,... |
Psychopharmacology |
1978 |
| Maj J, Palider W, Rawlów... |
The Effect of Haloperidol, Spiperone and Pimozide on the Flexor Reflex... |
J. Neural Transmissi... |
1978 |
| Maj J, Lewandowska A, Raw... |
Central Antiserotonin Action of Amitriptyline |
Pharmalopsycht. |
1979 |
| Samanin R, Mennini T, Fer... |
m-Chlorophenylpiperazine: A Central Serotonin Agonist Causing Powerful... |
Naunyn-Schmiedeberg'... |
1979 |
| Sypniewska M |
The Effect of Baclofen on the Hind Limb Flexor Reflex of the Spinal Ra... |
Pol. J. Pharmacol. P... |
1979 |
| Winter JC |
Effects of the phenethylamine derivatives, BL-3912, fenfluramine, and ... |
Psychopharmacology |
1980 |
| White FJ, Appel JB |
A Neuropharmacological Analysis of the Discriminative Stimulus Propert... |
Psychopharmacology |
1981 |
| Langer SZ, Moret C |
Citalopram Antagonizes the Stimulation by Lysergic Acid Diethylamide o... |
J. Pharm. Exper. The... |
1982 |
| Maj J, Vetulani J, Michal... |
Central Action of Amitriptyline N-oxide |
Pharmacopsychiat. |
1982 |
| Pawlowski L, Nowak G, Gór... |
Ro 11-2465 (cyan-imipramine), citalopram and their N-desmethyl metabol... |
Psychopharmacology |
1985 |
| Kmieciak-Kolada K, Kowals... |
Involvement of the central serotoninergic system in the changes of leu... |
Neuropeptides |
1986 |
| Schechter MD |
Discriminative profile of MDMA |
Pharmacol Biochem Be... |
1986 |
| McKenney JD, Glennon RA |
TFMPP May Produce its Stimulus Effects Via a 5-HT1B Mechanism |
Pharmacology Biochem... |
1986 |
| Beeghly JH, Kuperman S, P... |
Fenfluramine treatment of autism: relationship of treatment response t... |
J Autism Dev Disord |
1987 |
| Callahan PM, Appel JB |
Differences in the stimulus properties of 3,4-methylenedioxyamphetamin... |
J Pharmacol Exp Ther |
1988 |
| Schechter MD |
Use of TFMPP stimulus properties as a model of 5-HT1B receptor activat... |
Pharmacol Biochem Be... |
1988 |
| Schechter MD |
Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetami... |
Pharmacol Biochem Be... |
1989 |
| Lorens SA, Hata N, Cabrer... |
Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDM... |
NIDA Res Monogr |
1989 |
| Stone DM, Johnson M, Hans... |
Acute inactivation of tryptophan hydroxylase by amphetamine analogs in... |
Eur J Pharmacol |
1989 |
| Zaczek R, Hurt S, Culp S,... |
Characterization of brain interactions with methylenedioxyamphetamine ... |
NIDA Res Monogr |
1989 |
| Kleven MS, Seiden LS |
Toxicity of Amphetamine-related Drugs and Resulting Behavioural Change... |
NIDA Res Monogr |
1989 |
| Evans SM, Zacny JP, Johan... |
Three-choice discrimination among (+)-amphetamine, fenfluramine and sa... |
Pharmacol Biochem Be... |
1990 |
| Molliver ME, Berger UV, M... |
Neurotoxicity of MDMA and related compounds: anatomic studies |
Ann N Y Acad Sci |
1990 |
| McKenna DJ, Guan XM, Shul... |
3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential eff... |
Pharmacol Biochem Be... |
1991 |
| Schechter MD |
Effect of serotonin depletion by p-chlorophenylalanine upon discrimina... |
Gen Pharmacol |
1991 |
| Boja JW, Schechter MD |
Possible serotonergic and dopaminergic mediation of the N-ethyl-3,4-me... |
Eur J Pharmacol |
1991 |
| Young R |
Aminorex produces stimulus effects similar to amphetamine and unlike t... |
Pharmacol Biochem Be... |
1992 |
| Berger UV, Gu XF, Azmitia... |
The substituted amphetamines 3,4-methylenedioxymethamphetamine, metham... |
Eur J Pharmacol |
1992 |
| Kehne JH, McCloskey TC, T... |
Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (... |
J Pharmacol Exp Ther |
1992 |
| Lehmann J, DeSouza EB, Cu... |
Regional distribution to recovery of 5-HT levels after administration ... |
Ann N Y Acad Sci |
1992 |
| Marchant NC, Breen MA, Wa... |
Comparative biodisposition and metabolism of 14C-(+/-)-fenfluramine in... |
Xenobiotica |
1992 |
| Colado MI, Murray TK, Gre... |
5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MD... |
Br J Pharmacol |
1993 |
| Miller DB, O'Callaghan JP |
The interactions of MK-801 with the amphetamine analogues D-methamphet... |
Ann N Y Acad Sci |
1993 |
| Schechter MD, Gordon TL |
Comparison of the behavioral effects of ibogaine from three sources: m... |
Eur J Pharmacol |
1993 |
| Schuldiner S, Steiner-Mor... |
Amphetamine Derivatives Interact with Both Plasma Membrane and Secreto... |
Mol Pharmacol |
1993 |
| Kramer K, Azmitia EC, Whi... |
In vitro release of [3H]5-hydroxytryptamine from fetal and maternal br... |
Brain Res Dev Brain ... |
1994 |
| Leonardi ETK, Azmitia EC |
MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with f... |
Neuropsychopharmacol... |
1994 |
| Marona-Lewicka D, Nichols... |
Behavioral effects of the highly selective serotonin releasing agent 5... |
Eur J Pharmacol |
1994 |
| Miller DB, O'Callaghan JP |
Environment-, drug- and stress-induced alterations in body temperature... |
J Pharmacol Exp Ther |
1994 |
| O'Callaghan JP, Miller DB |
Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mou... |
J Pharmacol Exp Ther |
1994 |
| Scheffel U, Dannals RF, S... |
Development of PET/SPECT ligands for the serotonin transporter |
NIDA Res Monogr |
1994 |
| Series HG, Cowen PJ, Shar... |
p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) a... |
Psychopharmacology (... |
1994 |
| Heller A, Won L, Heller B... |
Examination of developmental neurotoxicity by the use of tissue cultur... |
Clin Exp Pharmacol P... |
1995 |
| Miller DB, O'Callaghan JP |
The role of temperature, stress, and other factors in the neurotoxicit... |
Mol Neurobiol |
1995 |
| Sabol KE, Richards JB, La... |
Amphetamine analogs have differential effects on DRL 36-s schedule per... |
Psychopharmacology (... |
1995 |
| Wichems CH, Hollingsworth... |
Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDM... |
Brain Res |
1995 |
| Baker LE, Makhay MM |
Effects of (+)-fenfluramine on 3,4-methylenedioxymethamphetamine (MDMA... |
Pharmacol Biochem Be... |
1996 |
| Marona-Lewicka D, Rhee GS... |
Reinforcing effects of certain serotonin-releasing amphetamine derivat... |
Pharmacol Biochem Be... |
1996 |
| Padich RA, McCloskey TC, ... |
5-HT modulation of auditory and visual sensorimotor gating: II. Effect... |
Psychopharmacology (... |
1996 |
| Saunders N |
Ecstasy and neurodegeneration. No Evidence of Neurotoxicity Exists |
BMJ |
1996 |
| Murray TK, Williams JL, M... |
The spin trap reagent PBN attenuates degeneration of 5-HT neurones in ... |
Neuropharmacology |
1996 |
| Kehne JH, Padich RA, Kett... |
5-HT modulation of auditory and visual sensorimotor gating: I. Effects... |
Psychopharmacology (... |
1996 |
| Crespi D, Mennini T, Gobb... |
Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induc... |
Br J Pharmacol |
1997 |
| Colado MI, O'Shea E, Gran... |
In vivo evidence for free radical involvement in the degeneration of r... |
Br J Pharmacol |
1997 |
| Bogusz MJ, Kala M, Maier ... |
Determination of phenylisothiocyanate derivatives of amphetamine and i... |
J Anal Toxicol |
1997 |
| Zheng Y, Russell B, Schmi... |
The effects of aminorex and related compounds on brain monoamines and ... |
J Pharm Pharmacol |
1997 |
| Schechter MD |
Drug-drug discrimination: stimulus properties of drugs of abuse upon a... |
Pharmacol Biochem Be... |
1997 |
| Glennon RA, Young R, Duka... |
Initial characterization of PMMA as a discriminative stimulus |
Pharmacol Biochem Be... |
1997 |
| Baker LE, Virden TB, Mill... |
Time course analysis of the discriminative stimulus effects of the opt... |
Pharmacol Biochem Be... |
1997 |
| Poland RE, Lutchmansingh ... |
Abnormal ACTH and prolactin responses to fenfluramine in rats exposed ... |
Psychopharmacology (... |
1997 |
| Schechter MD |
Serotonergic mediation of fenfluramine discriminative stimuli in fawn-... |
Life Sci |
1997 |
| Gerra G, Zaimovic A, Giuc... |
Serotonergic function after (+/-)3,4-methylene-dioxymethamphetamine ('... |
Int Clin Psychopharm... |
1998 |
| Dafters RI, Lynch E |
Persistent loss of thermoregulation in the rat induced by 3,4-methylen... |
Psychopharmacology (... |
1998 |
| Frederick DL, Ali SF, Gil... |
Acute effects of dexfenfluramine (d-FEN) and methylenedioxymethampheta... |
Ann N Y Acad Sci |
1998 |
| Fleckenstein AE, Haughey ... |
Differential effects of psychostimulants and related agents on dopamin... |
Eur J Pharmacol |
1999 |
| Connor TJ, Kelly JP, McGe... |
Methylenedioxymethamphetamine (MDMA; Ecstasy) suppresses IL-1b and TNF... |
Life Sci |
2000 |
| Connor TJ , Kelly JP, Leo... |
An assessment of the acute effects of the serotonin releasers methylen... |
Immunopharmacology |
2000 |
| Bogusz MJ, Kruger KD, Mai... |
Analysis of underivatized amphetamines and related phenethylamines wit... |
J Anal Toxicol |
2000 |
| Gerra G, Zaimovic A, Ferr... |
Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstas... |
Biol Psychiatry |
2000 |
| Goodwin AK, Baker LE |
A three-choice discrimination procedure dissociates the discriminative... |
Exp Clin Psychopharm... |
2000 |
| Kalia M, O'Callaghan JP, ... |
Comparative study of fluoxetine, sibutramine, sertraline and dexfenflu... |
Brain Res |
2000 |
| Russell BR, Laverty R |
Correlation between 5-HT content and uptake site density following (S)... |
Ann N Y Acad Sci |
2000 |
| Felscher D, Schulz K |
Screening of Amphetamine/Methamphetamine and their Derivatives in Urin... |
J Forensic Sci |
2000 |
| Baumann MH, Ayestas MA, D... |
1-(m-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin rele... |
Neuropsychopharmacol... |
2001 |
| Verkes RJ, Gijsman HJ, Pi... |
Cognitive performance and serotonergic function in users of ecstasy |
Psychopharmacology (... |
2001 |
| Callahan BT, Cord BJ, Ric... |
Long-Term Impairment of Anterograde Axonal Transport Along Fiber Proje... |
Synapse |
2001 |
| Russell BR, Laverty R |
The effect of (R)-HA966 or ACEA 1021 on dexfenfluramine or (S)-MDMA-in... |
Pharmacology, Bioche... |
2001 |
| Bankson MB, Cunningham KA |
3,4-Methylenedioxymethamphetamine (MDMA) as a Unique Model of Serotoni... |
Journal of Pharmacol... |
2001 |
| Biello, SM, Dafters, RI |
MDMA and fenfluramine alter the response of the circadian clock to a s... |
Brain Research |
2001 |
| Parrott AC |
Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic ne... |
Pharmacol Biochem Be... |
2002 |
| Winsauer PJ, McCann UD, Y... |
Effects of fenfluramine, m-CPP and triazolam on repeated-acquisition i... |
Psychopharmacology (... |
2002 |
| Bankson MG, Cunningham KA |
Pharmacological Studies of the Acute Effects of (+)-3,4- Methylenediox... |
Neuropsychopharmacol... |
2002 |
| Young R, Glennon RA |
The stimulus effect of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5- g]isoquinol... |
Pharmacol Biochem Be... |
2002 |
| Hatzidimitriou G, Tsai EH... |
Altered prolactin response to M-chlorophenylpiperazine in monkeys prev... |
Synapse |
2002 |
| Rothman R, Baumann M |
Therapeutic and adverse actions of serotonin transporter substrates |
Pharmacol Ther |
2002 |
